Group 1 - Balchem reported quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.36 per share, but showing an increase from $1.03 per share a year ago, resulting in an earnings surprise of -0.74% [1] - The company posted revenues of $267.56 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.92%, compared to year-ago revenues of $239.94 million [2] - Over the last four quarters, Balchem has surpassed consensus revenue estimates three times, indicating a generally positive trend in revenue performance [2] Group 2 - Balchem shares have underperformed the market, losing about 7.5% since the beginning of the year, while the S&P 500 has gained 14.5% [3] - The current consensus EPS estimate for the coming quarter is $1.35 on revenues of $265.69 million, and for the current fiscal year, it is $5.20 on revenues of $1.03 billion [7] - The Zacks Industry Rank for Chemical - Specialty is currently in the bottom 30% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8]
Balchem (BCPC) Q3 Earnings Lag Estimates (Revised)